Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review
C Chen, SR Haupert, L Zimmermann… - The Journal of …, 2022 - academic.oup.com
Background This study aims to examine the worldwide prevalence of post-coronavirus
disease 2019 (COVID-19) condition, through a systematic review and meta-analysis …
disease 2019 (COVID-19) condition, through a systematic review and meta-analysis …
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
B Raman, DA Bluemke, TF Lüscher… - European heart …, 2022 - academic.oup.com
Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …
[HTML][HTML] Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients
Background COVID-19 is associated with increased risks of neurological and psychiatric
sequelae in the weeks and months thereafter. How long these risks remain, whether they …
sequelae in the weeks and months thereafter. How long these risks remain, whether they …
[HTML][HTML] Persistent COVID-19 symptoms in a community study of 606,434 people in England
Long COVID remains a broadly defined syndrome, with estimates of prevalence and
duration varying widely. We use data from rounds 3–5 of the REACT-2 study (n= 508,707; …
duration varying widely. We use data from rounds 3–5 of the REACT-2 study (n= 508,707; …
[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post–COVID-19 conditions
Importance Few risk factors for long-lasting (≥ 4 weeks) COVID-19 symptoms have been
identified. Objective To determine whether high levels of psychological distress before …
identified. Objective To determine whether high levels of psychological distress before …
[HTML][HTML] Comorbidities, multimorbidity and COVID-19
The influence of comorbidities on COVID-19 outcomes has been recognized since the
earliest days of the pandemic. But establishing causality and determining underlying …
earliest days of the pandemic. But establishing causality and determining underlying …
[PDF][PDF] The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19
C Schultheiß, E Willscher, L Paschold, C Gottschick… - Cell Reports …, 2022 - cell.com
Post-acute sequelae of COVID-19 (PASC) is emerging as global problem with unknown
molecular drivers. Using a digital epidemiology approach, we recruited 8,077 individuals to …
molecular drivers. Using a digital epidemiology approach, we recruited 8,077 individuals to …
[HTML][HTML] Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
Background England's COVID-19 roadmap out of lockdown policy set out the timeline and
conditions for the stepwise lifting of non-pharmaceutical interventions (NPIs) as vaccination …
conditions for the stepwise lifting of non-pharmaceutical interventions (NPIs) as vaccination …